BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 18752948)

  • 1. Monoacylglycerol lipase regulates 2-arachidonoylglycerol action and arachidonic acid levels.
    Nomura DK; Hudak CS; Ward AM; Burston JJ; Issa RS; Fisher KJ; Abood ME; Wiley JL; Lichtman AH; Casida JE
    Bioorg Med Chem Lett; 2008 Nov; 18(22):5875-8. PubMed ID: 18752948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative biochemical characterization of the monoacylglycerol lipase inhibitor KML29 in brain, spinal cord, liver, spleen, fat and muscle tissue.
    Pasquarelli N; Porazik C; Hanselmann J; Weydt P; Ferger B; Witting A
    Neuropharmacology; 2015 Apr; 91():148-56. PubMed ID: 25497453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoacylglycerol lipase inhibition by organophosphorus compounds leads to elevation of brain 2-arachidonoylglycerol and the associated hypomotility in mice.
    Quistad GB; Klintenberg R; Caboni P; Liang SN; Casida JE
    Toxicol Appl Pharmacol; 2006 Feb; 211(1):78-83. PubMed ID: 16310817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of the endocannabinoid system by organophosphorus nerve agents.
    Nomura DK; Blankman JL; Simon GM; Fujioka K; Issa RS; Ward AM; Cravatt BF; Casida JE
    Nat Chem Biol; 2008 Jun; 4(6):373-8. PubMed ID: 18438404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of monoacylglycerol lipase and fatty acid amide hydrolase by analogues of 2-arachidonoylglycerol.
    Ghafouri N; Tiger G; Razdan RK; Mahadevan A; Pertwee RG; Martin BR; Fowler CJ
    Br J Pharmacol; 2004 Nov; 143(6):774-84. PubMed ID: 15492019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of monoacylglycerol lipase inhibition on intestinal permeability in chronic stress model.
    Wang J; Zhang X; Yang C; Zhao S
    Biochem Biophys Res Commun; 2020 May; 525(4):962-967. PubMed ID: 32173532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic deletion of monoacylglycerol lipase leads to impaired cannabinoid receptor CB₁R signaling and anxiety-like behavior.
    Imperatore R; Morello G; Luongo L; Taschler U; Romano R; De Gregorio D; Belardo C; Maione S; Di Marzo V; Cristino L
    J Neurochem; 2015 Nov; 135(4):799-813. PubMed ID: 26223500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoacylglycerol lipase (MAGL) inhibition attenuates acute lung injury in mice.
    Costola-de-Souza C; Ribeiro A; Ferraz-de-Paula V; Calefi AS; Aloia TP; Gimenes-Júnior JA; de Almeida VI; Pinheiro ML; Palermo-Neto J
    PLoS One; 2013; 8(10):e77706. PubMed ID: 24204926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabinoid receptor-dependent metabolism of 2-arachidonoylglycerol during aging.
    Pascual AC; Gaveglio VL; Giusto NM; Pasquaré SJ
    Exp Gerontol; 2014 Jul; 55():134-42. PubMed ID: 24768821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disulfiram is an inhibitor of human purified monoacylglycerol lipase, the enzyme regulating 2-arachidonoylglycerol signaling.
    Labar G; Bauvois C; Muccioli GG; Wouters J; Lambert DM
    Chembiochem; 2007 Jul; 8(11):1293-7. PubMed ID: 17579916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological inhibition of 2-arachidonoilglycerol hydrolysis enhances memory consolidation in rats through CB2 receptor activation and mTOR signaling modulation.
    Ratano P; Petrella C; Forti F; Passeri PP; Morena M; Palmery M; Trezza V; Severini C; Campolongo P
    Neuropharmacology; 2018 Aug; 138():210-218. PubMed ID: 29842858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol.
    Blankman JL; Simon GM; Cravatt BF
    Chem Biol; 2007 Dec; 14(12):1347-56. PubMed ID: 18096503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of monoacylglycerol lipase reduces nicotine reward in the conditioned place preference test in male mice.
    Muldoon PP; Akinola LS; Schlosburg JE; Lichtman AH; Sim-Selley LJ; Mahadevan A; Cravatt BF; Damaj MI
    Neuropharmacology; 2020 Oct; 176():108170. PubMed ID: 32479813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects.
    Long JZ; Li W; Booker L; Burston JJ; Kinsey SG; Schlosburg JE; Pavón FJ; Serrano AM; Selley DE; Parsons LH; Lichtman AH; Cravatt BF
    Nat Chem Biol; 2009 Jan; 5(1):37-44. PubMed ID: 19029917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic Interplay between Astrocytes and Neurons Regulates Endocannabinoid Action.
    Viader A; Blankman JL; Zhong P; Liu X; Schlosburg JE; Joslyn CM; Liu QS; Tomarchio AJ; Lichtman AH; Selley DE; Sim-Selley LJ; Cravatt BF
    Cell Rep; 2015 Aug; 12(5):798-808. PubMed ID: 26212325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coordinated regulation of endocannabinoid-mediated retrograde synaptic suppression in the cerebellum by neuronal and astrocytic monoacylglycerol lipase.
    Liu X; Chen Y; Vickstrom CR; Li Y; Viader A; Cravatt BF; Liu QS
    Sci Rep; 2016 Oct; 6():35829. PubMed ID: 27775008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain regional cannabinoid CB(1) receptor signalling and alternative enzymatic pathways for 2-arachidonoylglycerol generation in brain sections of diacylglycerol lipase deficient mice.
    Aaltonen N; Riera Ribas C; Lehtonen M; Savinainen JR; Laitinen JT
    Eur J Pharm Sci; 2014 Jan; 51():87-95. PubMed ID: 24012970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The constitutive production of the endocannabinoid 2-arachidonoylglycerol participates in oligodendrocyte differentiation.
    Gomez O; Arevalo-Martin A; Garcia-Ovejero D; Ortega-Gutierrez S; Cisneros JA; Almazan G; Sánchez-Rodriguez MA; Molina-Holgado F; Molina-Holgado E
    Glia; 2010 Dec; 58(16):1913-27. PubMed ID: 20878765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocannabinoid hydrolysis generates brain prostaglandins that promote neuroinflammation.
    Nomura DK; Morrison BE; Blankman JL; Long JZ; Kinsey SG; Marcondes MC; Ward AM; Hahn YK; Lichtman AH; Conti B; Cravatt BF
    Science; 2011 Nov; 334(6057):809-13. PubMed ID: 22021672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of hippocampal CB1 receptor desensitization by Δ(9)-tetrahydrocannabinol in aged mice and by low doses of JZL 184.
    Feliszek M; Bindila L; Lutz B; Zimmer A; Bilkei-Gorzo A; Schlicker E
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Jun; 389(6):603-12. PubMed ID: 26984820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.